Detalles de la búsqueda
1.
Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
Osteoporos Int;
34(1): 189-199, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36239756
2.
Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study.
Calcif Tissue Int;
110(1): 87-92, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427705
3.
Acute Phase Reactions After Intravenous Infusion of Zoledronic Acid in Japanese Patients with Osteoporosis: Sub-analyses of the Phase III ZONE Study.
Calcif Tissue Int;
109(6): 666-674, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34247263
4.
FAM210A is a novel determinant of bone and muscle structure and strength.
Proc Natl Acad Sci U S A;
115(16): E3759-E3768, 2018 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29618611
5.
Graves' disease and vertebral fracture: Possible pathogenic link in postmenopausal women.
Clin Endocrinol (Oxf);
93(2): 204-211, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324288
6.
Modulators of Fam210a and Roles of Fam210a in the Function of Myoblasts.
Calcif Tissue Int;
106(5): 533-540, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31980842
7.
Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis.
Calcif Tissue Int;
107(6): 559-566, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32839843
8.
Design of a randomized trial of teriparatide followed by alendronate: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).
J Bone Miner Metab;
38(3): 412-417, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31894491
9.
Papillary thyroid carcinoma is a risk factor for severe osteoporosis.
J Bone Miner Metab;
38(2): 264-270, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31664535
10.
Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status.
J Bone Miner Metab;
38(6): 848-858, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32671481
11.
Management manual for cancer treatment-induced bone loss (CTIBL): position statement of the JSBMR.
J Bone Miner Metab;
38(2): 141-144, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32020289
12.
Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis.
J Bone Miner Metab;
38(1): 86-98, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420748
13.
Executive summary of clinical practice guide on fracture risk in lifestyle diseases.
J Bone Miner Metab;
38(6): 746-758, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32892240
14.
A pregnant woman with an autonomously functioning thyroid nodule: a case report.
Gynecol Endocrinol;
36(12): 1140-1143, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32954874
15.
Bazedoxifene Ameliorates Homocysteine-Induced Apoptosis via NADPH Oxidase-Interleukin 1ß and 6 Pathway in Osteocyte-like Cells.
Calcif Tissue Int;
105(4): 446-457, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31250042
16.
Insulin-Like Growth Factor-I Protects Against the Detrimental Effects of Advanced Glycation End Products and High Glucose in Myoblastic C2C12 Cells.
Calcif Tissue Int;
105(1): 89-96, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30809689
17.
Overweight and underweight are risk factors for vertebral fractures in patients with type 2 diabetes mellitus.
J Bone Miner Metab;
37(4): 703-710, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30238431
18.
Osteoporosis and vertebral fracture are associated with deterioration of activities of daily living and quality of life in patients with type 2 diabetes mellitus.
J Bone Miner Metab;
37(3): 503-511, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30191456
19.
Changes in quality of life in patients with postmenopausal osteoporosis receiving weekly bisphosphonate treatment: a 2-year multicenter study in Japan.
J Bone Miner Metab;
37(2): 273-281, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523963
20.
Efficacy and safety of once-monthly risedronate in osteoporosis subjects with mild-to-moderate chronic kidney disease: a post hoc subgroup analysis of a phase III trial in Japan.
J Bone Miner Metab;
37(4): 730-740, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30523414